Stockholders approve CVS Health’s acquisition of Aetna – Drug for nerve pain boosts high for opioid abusers.

16321_pharmacyboard_standard_080416Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Stockholders approve CVS Health’s acquisition of Aetna – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

Shareholders of CVS Health and Aetna voted on Tuesday to approve CVS’s $69 billion acquisition of Aetna. According to preliminary results from the special meeting, more than 98% of the shares voted supported the deal, CVS said, while about 97% of Aetna shareholders voted in favor of the transaction. The deal is expected to close later this year, subject to regulatory approvals. “When this merger is complete, the combined company will be well-positioned to reshape the consumer health care experience, putting people at the center of health care delivery to ensure they have access to high-quality, more affordable care where they are, when they need it,” CVS Health President and CEO Larry Merlo said.

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.